文献速递创伤与烧伤重症综合管理与镇静镇痛

可溶性ST2预测烧伤患者住院死亡率:一项观察性前瞻性队列预试验

Soluble Suppression Of Tumorigenicity-2 Predicts Hospital Mortality in Burn Patients: An Observational Prospective Cohort Pilot Study.
PubMed 文献 · Shock · 2019-01-01
一句话结论烧伤患者入院第3天血浆sST2≥2,561与住院死亡显著相关(HR 6.94),曲线下面积0.85。

单中心前瞻性观察性队列预试验纳入69例≥18岁需收入烧伤病房的二度或三度烧伤患者,在入院24小时内及第3天检测IL6、IL8、IL33和sST2。13例(18.8%)在烧伤病房死亡。第3天sST2对生存的预测准确度最高(AUC 0.85 [0.71-0.99],P<0.001),最佳截断值为2,561。校正潜在混杂后,第3天sST2≥2,561与死亡率显著相关(HR 6.94 [1.73-27.74],P=0.006)。作者结论认为第3天血浆sST2可预测烧伤患者住院死亡率。

要点

  • 烧伤患者入院第3天sST2预测住院死亡的AUC为0.85(0.71-0.99),P<0.001。
  • 第3天sST2最佳截断值为2,561;≥2,561者死亡风险显著升高(HR 6.94 [1.73-27.74],P=0.006)。
  • 69例患者中13例(18.8%)在烧伤病房死亡;男性58例(84.1%),平均年龄52(35-63)岁,烧伤总面积21%(13%-30%),简明烧伤严重指数6(4-8)。
  • 入院24小时内及第3天检测IL6、IL8、IL33和sST2,其中第3天sST2预测准确度最高。

适用人群与场景

  • 年龄≥18岁、二度或三度烧伤需收入烧伤病房的患者;单中心为Vall d'Hebron大学医院整形与重建外科烧伤病房。

诊断标准与关键阈值

  • 第3天血浆sST2最佳截断值为2,561,用于预测住院死亡。

研究设计与关键结果

  • 单中心前瞻性观察性队列预试验,纳入69例烧伤患者,13例(18.8%)在烧伤病房死亡。
  • 第3天sST2预测生存的AUC为0.85(0.71-0.99),P<0.001;最佳截断值为2,561。
  • Cox比例风险模型校正潜在混杂后,第3天sST2≥2,561与死亡率显著相关(HR 6.94 [1.73-27.74],P=0.006)。

证据类型、等级与局限

  • 证据类型:单中心前瞻性观察性队列预试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为第3天血浆sST2可预测烧伤患者住院死亡率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The IL33/ST2 pathway has been implicated in the pathogenesis of different inflammatory diseases. Our aim was to analyze whether plasma levels of biomarkers involved in the IL33/ST2 axis might help to predict mortality in burn patients.

METHODS: Single-center prospective observational cohort pilot study performed at the Burns Unit of the Plastic and Reconstructive Surgery Department of the Vall d'Hebron University Hospital (Barcelona). All patients aged ≥18 years old with second or third-degree burns requiring admission to the Burns Unit were considered for inclusion. Blood samples were taken to measure levels of interleukins (IL)6, IL8, IL33, and soluble suppression of tumorigenicity-2 (sST2) within 24 h of admission to the Burns Unit and at day 3. Results are expressed as medians and interquartile ranges or as frequencies and percentages.

RESULTS: Sixty-nine patients (58 [84.1%] male, mean age 52 [35-63] years, total body surface area burned 21% [13%-30%], Abbreviated Burn Severity Index 6 [4-8]) were included. Thirteen (18.8%) finally died in the Burns Unit. Plasma levels of sST2 measured at day 3 after admission demonstrated the best prediction accuracy for survival (area under the receiver-operating curve 0.85 [0.71-0.99]; P < 0.001). The best cutoff point for the area under the receiver-operating curve index was estimated to be 2,561. In the Cox proportional hazards model, after adjusting for potential confounding, a plasma sST2 level ≥2,561 measured at day 3 was significantly associated with mortality (hazard ratio 6.94 [1.73-27.74]; P = 0.006).

CONCLUSIONS: Plasma sST2 at day 3 predicts hospital mortality in burn patients.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Ruiz-Castilla M, Bosacoma P, Dos Santos B, et al. Soluble Suppression Of Tumorigenicity-2 Predicts Hospital Mortality in Burn Patients: An Observational Prospective Cohort Pilot Study. Shock. 2019. PMID: 29642231. doi:10.1097/SHK.0000000000001155

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。